Saturday, April 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

D-Wave Quantum Faces a Pivotal Earnings Test as Nvidia Euphoria Fades

SiterGedge by SiterGedge
April 25, 2026
in AI & Quantum Computing, Earnings, Insider Trading
0
D-Wave Quantum Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The wild ride for D-Wave Quantum shares is entering a more sobering phase. After surging from roughly $13 to above $22 in April on the back of Nvidia’s quantum-focused AI model announcement, the stock has pulled back sharply, leaving investors to wonder whether the fundamentals can support the hype.

The company has confirmed it will report first-quarter results on May 12, 2026, before the market opens. The stakes are high. In the prior quarter, D-Wave missed consensus estimates by a wide margin, posting a loss of $0.09 per share against expectations of $0.05. Another disappointing print could accelerate the current downturn.

A Technical No-Man’s Land

On Friday, shares closed at $18.62, down roughly 3.5% on the day. Trading volume was notably thin at just under 17.7 million shares — less than half the daily average of around 44.9 million. Market observers interpret the low volume as fading momentum rather than panic selling.

The stock now sits in a technical grey zone. The 50-day moving average stands at $17.47, while the 200-day average is at $24.21. With the current price trapped between these two levels, the chart offers little directional clarity.

Insider Sales Add to the Overhang

A recent SEC filing drew attention mid-week. Sophie Ames, Executive Vice President and Chief Human Resources Officer, sold approximately 3,070 shares on April 20 at an average price of $21.35, netting just over $65,500. The transaction was executed under a 10b5-1 trading plan established in June 2025, making it a routine, pre-planned move. Ames still holds roughly 643,000 shares directly, the vast majority of which are unearned restricted stock units.

The insider selling pattern extends beyond Ames. Over the past three months, executives have sold more shares than they have bought. Adding to the pressure, the company’s share count has expanded by more than a quarter over the past year, diluting existing holders.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Analysts Trim Targets but Stay Bullish

Wall Street is recalibrating its expectations ahead of the report. Mizuho cut its price target from $40 to $31, while Evercore ISI lowered its target from $44 to $42. Both firms maintain their “Outperform” ratings. The consensus among 15 analysts points to a price target of $32.53, implying roughly 75% upside from current levels.

Cash-Rich but Burning Through It

D-Wave’s balance sheet offers some comfort. The company holds approximately $635 million in cash against just $42 million in long-term debt. Revenue surged 179% in fiscal 2025. However, the company is burning through about $20 million in free cash flow per quarter as it invests in scaling its quantum technology.

Management has described the path to profitability as fully funded. The question is whether the pipeline can convert into revenue fast enough to justify the current valuation.

The Nvidia Effect Fades

The April rally was triggered by Nvidia’s announcement of its Ising model family, designed to boost quantum processor performance. D-Wave, along with peers IonQ and Rigetti, rode the wave. That enthusiasm is now dissipating, leaving the stock to trade on its own merits.

The May 12 report will be the first real test of whether D-Wave can turn its massive order backlog — which dwarfed the prior year’s bookings as early as January — into tangible revenue. CEO Alan Baratz and CFO John Markovich will need to show that the pipeline is not just growing, but converting.

Ad

D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from April 25 delivers the answer:

The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.

D-Wave Quantum: Buy or sell? Read more here...

Tags: D-Wave Quantum
SiterGedge

SiterGedge

Related Posts

Eli Lilly Stock
Analysis

Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings

April 25, 2026
Salesforce Stock
AI & Quantum Computing

Salesforce Stock Sinks 31% This Year Despite $25 Billion Buyback and Google AI Deal

April 25, 2026
ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn

April 25, 2026
Next Post
AMD Stock

AMD's Record Run: How Intel's Surprise Quarter Ignited a CPU Revolution

MSCI World ETF Stock

A $1.75 Trillion Shadow Looms Over the MSCI World ETF

Nvidia Stock

Nvidia’s $5 Trillion Club Entry Masks a Troubling Gap With Rivals

Recommended

PayPal Stock

PayPal’s Dividend Debut Fails to Rally Investor Confidence

5 months ago
Pagerduty Inc Stock

PagerDuty’s Crucial Earnings Report: A Test of AI Strategy and Investor Confidence

2 months ago
Mednax Stock

Major Funds Exit Mednax Holdings Despite Stock Surge

5 months ago
CF Industries Stock

CF Industries Navigates Strong Earnings Amid Cost Challenges

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

TeamViewer’s Recovery Hangs on a Knife-Edge Ahead of Q1 Results

Antimony Resources Puts Bald Hill on the Cusp of a Formal Resource Count

Rheinmetall’s Record Order Book Can’t Mask a 52-Week Low as Q1 Results Approach

Ocugen’s Analyst Consensus Is Unanimously Bullish — But the Charts Tell a Different Story

Thyssenkrupp’s Spring of Reckoning: A €37 Billion Canadian Bet Meets a Bleeding Steel Core

European Lithium’s Trading Halt Puts Spotlight on Capital Clean-Up and Greenland Progress

Trending

Eli Lilly Stock
Analysis

Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings

by Jackson Burston
April 25, 2026
0

Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday,...

Salesforce Stock

Salesforce Stock Sinks 31% This Year Despite $25 Billion Buyback and Google AI Deal

April 25, 2026
ImmunityBio Stock

ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn

April 25, 2026
TeamViewer Stock

TeamViewer’s Recovery Hangs on a Knife-Edge Ahead of Q1 Results

April 25, 2026
Antimony Resources Stock

Antimony Resources Puts Bald Hill on the Cusp of a Formal Resource Count

April 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings
  • Salesforce Stock Sinks 31% This Year Despite $25 Billion Buyback and Google AI Deal
  • ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com